JASON ALFORD: Open Payments
NPI 1164048385 · KERNERSVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 33 payments from 9 companies in 2025. Trend: 2023 $188 · 2024 $432 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $250 |
| ANI Pharmaceuticals, Inc. | 4 | $60 |
| Travere Therapeutics, Inc. | 3 | $58 |
| Novo Nordisk Inc | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Fabhalta, PURIFIED CORTROPHIN GEL, TERLIVAZ, FARXIGA, Rivfloza, Ozempic, BENLYSTA, JARDIANCE.
Industry payments across NC — which companies pay providers there.
